CXCL16 and prostate carcinoma: Our preliminary screen for chemokine expression suggested a role for CXCL16, and we found that both CXCL16 and CXCR6 were co-expressed on cancer cells, that their levels of expression correlated with each other, and that these levels also correlated with high-stage and high-grade prostate cancer.